Gene · 3003
NIH grants2,103
NIH grants whose papers are about the gene, through NIH's grant-paper links.
661 to 680 of 2,103
Download this page as JSON| Grant | Title | GZMK papers | Newest fiscal year |
|---|---|---|---|
| R01CA236910 | Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance | 2 | 2024 |
| R35GM136259 | Regulation of cell function by mechanical properties of biopolymer networks and lipid bilayers | 2 | 2024 |
| R35HG011292 | Omics information maximization in single-cell sequencing with hybrid molecular and computational approaches | 2 | 2024 |
| R37AI059371 | RNA Processing in Non-Segmented Minus-Strand RNA Viruses | 2 | 2024 |
| T32AG062409 | Training Program in Precision Genetics of Aging, Alzheimer's Disease and Related Dementias | 2 | 2024 |
| T32AI007151 | Infectious Disease Pathogenesis Research Training Program | 2 | 2024 |
| T32CA009135 | Training in Cancer Biology Training Grant | 2 | 2024 |
| T32CA009140 | Immunobiology of Normal and Neoplastic Lymphocytes | 2 | 2024 |
| T32CA078207 | Training Program in Cancer Biology | 2 | 2024 |
| T32GM007863 | Michigan Medical Scientist Training Program | 2 | 2024 |
| U01AI150747 | DYNAMICS AND EVOLUTION OF IMMUNE RESPONSES TO INFLUENZA VIRUSES | 2 | 2024 |
| U01CA260852 | 4DN Interrogation of T Cell Exhaustion in Cancer | 2 | 2024 |
| U54CA260543 | North Carolina Seronet Center for Excellence | 2 | 2024 |
| DP1AI158186 | Unraveling the bat humoral immune response against zoonotic viruses to guide the design of next-generation therapeutics | 1 | 2024 |
| F31CA265085 | Regulation and role of fibroblast-derived interleukin-33 in the pancreatic tumor microenvironment | 1 | 2024 |
| F31CA275289 | Elucidating the Role of Tregs in Cancer Metastasis and T Cell Dysfunction | 1 | 2024 |
| F31HL164031 | Impact of interferon λ signaling on lung macrophage function and type 17 immunity during bacterial super-infection following influenza | 1 | 2024 |
| I01BX005117 | Hedgehog-Induced Activation of Alloimmune T Cells During Ischemia Reperfusion Injury | 1 | 2024 |
| IK2BX005301 | Natural killer cells in pulmonary ischemia-reperfusion injury | 1 | 2024 |
| K00AG073570 | Evaluating the role of cytomegalovirus and age on lung immune homeostaasis and response to respiratory infections | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/grants?page=34